159 results
Page 2 of 8
POS AM
pip6gqn mdn
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
wptba
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
EX-2.1
ntk3z9knu
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K/A
EX-99.1
6rt0pnp8 ok8ucbxsj
16 Nov 21
Results of Operations and Financial Condition
6:30am
8-K
EX-99.3
868oixrb q15it
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
S-3ASR
EX-1.2
6qkfkk8oxs8j39dl6jg
4 Mar 21
Automatic shelf registration
12:00am
S-3ASR
hcevzksd
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-1.1
v4jcmjou9fwj7
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
424B2
o543 erjt3cjv
16 Feb 21
Prospectus for primary offering
6:17am
424B5
j97xissaaf439z e324
10 Feb 21
Prospectus supplement for primary offering
5:11pm
424B5
hv1gcfu9vbiqf
27 Nov 20
Prospectus supplement for primary offering
4:46pm